Loading…

Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the coronavirus disease (COVID-19). It is confirmed that nucleocapsid (N) protein is closely related to viral pathogenesis, modulation of host immune response, RNA transcription, and replication and virus packaging...

Full description

Saved in:
Bibliographic Details
Published in:Applied microbiology and biotechnology 2022-02, Vol.106 (3), p.1151-1164
Main Authors: Tian, Yuanyuan, Zhang, Gaiping, Liu, Hongliang, Ding, Peiyang, Jia, Rui, Zhou, Jingming, Chen, Yumei, Qi, Yanhua, Du, Jinran, Liang, Chao, Zhu, Xifang, Wang, Aiping
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c471t-221ef80537eba2e13921460c607e3f8e627bc927e957ce90068087d1738629b43
cites cdi_FETCH-LOGICAL-c471t-221ef80537eba2e13921460c607e3f8e627bc927e957ce90068087d1738629b43
container_end_page 1164
container_issue 3
container_start_page 1151
container_title Applied microbiology and biotechnology
container_volume 106
creator Tian, Yuanyuan
Zhang, Gaiping
Liu, Hongliang
Ding, Peiyang
Jia, Rui
Zhou, Jingming
Chen, Yumei
Qi, Yanhua
Du, Jinran
Liang, Chao
Zhu, Xifang
Wang, Aiping
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the coronavirus disease (COVID-19). It is confirmed that nucleocapsid (N) protein is closely related to viral pathogenesis, modulation of host immune response, RNA transcription, and replication and virus packaging. Therefore, the N protein is a preponderant antigen target for virus detection. The codon-optimized N gene was designed according to the encoding characteristics of insect cells and inserted into pFastBac TM 1 vector with 6 × His-tag-fused N protein for expression in insect sf21 cells. Six anti–N mAbs (4G3, 5B3, 12B6, 18C7-A2, 21H10-A3, 21H10-E9) were prepared by recombinant N protein. The mAbs showed high titers, antibody affinity, and reactivity with the SARS-CoV-2 N protein. Then, fourteen overlapped peptides that covered the intact N protein were synthesized (N1-N14). Peptide N14 was identified as the main linear B-cell epitope region via peptide-ELISA and dot-blot assay, and this region was truncated gradually until mapping the peptide 401-DFSKQLQQ-408. Simultaneously, compared with the sequence of variants of concern (VOCs) and variants of interest (VOIs) strains among the several countries, epitope 401-DFSKQLQQ-408 is very conservative among them. The findings provide new guidance for the design and detection of COVID-19 targets. Key points • The N protein was optimized according to the insect cell codon preference and was highly expressed. • The monoclonal antibodies prepared in this study were shown high antibody titers and high affinity. • Monoclonal antibodies were used to map the epitope 401–408 amino acids of N protein for the first time in this study.
doi_str_mv 10.1007/s00253-022-11769-6
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8762450</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A691982578</galeid><sourcerecordid>A691982578</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-221ef80537eba2e13921460c607e3f8e627bc927e957ce90068087d1738629b43</originalsourceid><addsrcrecordid>eNp9kk2LFDEQhoMo7jj6BzxIwIuXXvPRnY-LMA6uCguCo15DOl09m6UnaZNu0X-_6Z111xWRBAJVT72VKl6EnlNySgmRrzMhrOEVYayiVApdiQdoRWvOKiJo_RCtCJVNJRutTtCTnC8JoUwJ8Rid8IZwqbVeoZ87lwCCD3tsQ4d9B2HyvXd28jHg2OO32MEwYBj9FEdYItMF4DC7AaKzY_YdHlOcwAdc7m7zeVdt47eK4Tkvogt8iCG6IQY7lB6Tb2PnIT9Fj3o7ZHh2867R17N3X7YfqvNP7z9uN-eVqyWdKsYo9Io0XEJrGVCuGa0FcYJI4L0CwWTrNJOgG-lAEyIUUbKjkivBdFvzNXpz1B3n9gCdK_MlO5gx-YNNv0y03tzPBH9h9vGHUVKwuuxpjV7dCKT4fYY8mYPPy05sgDhnwwQjUirFRUFf_oVexjmVua-ppqZUaH5H7e0Axoc-lr5uETUboalWrJGqUKf_oMrp4OBdDND7Er9XwI4FLsWcE_S3M1JiFr-Yo19M8Yu59otZfvziz-3clvw2SAH4EcglFfaQ7kb6j-wVvJDJlw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2625411693</pqid></control><display><type>article</type><title>Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies</title><source>ABI/INFORM Global</source><source>Springer Link</source><creator>Tian, Yuanyuan ; Zhang, Gaiping ; Liu, Hongliang ; Ding, Peiyang ; Jia, Rui ; Zhou, Jingming ; Chen, Yumei ; Qi, Yanhua ; Du, Jinran ; Liang, Chao ; Zhu, Xifang ; Wang, Aiping</creator><creatorcontrib>Tian, Yuanyuan ; Zhang, Gaiping ; Liu, Hongliang ; Ding, Peiyang ; Jia, Rui ; Zhou, Jingming ; Chen, Yumei ; Qi, Yanhua ; Du, Jinran ; Liang, Chao ; Zhu, Xifang ; Wang, Aiping</creatorcontrib><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the coronavirus disease (COVID-19). It is confirmed that nucleocapsid (N) protein is closely related to viral pathogenesis, modulation of host immune response, RNA transcription, and replication and virus packaging. Therefore, the N protein is a preponderant antigen target for virus detection. The codon-optimized N gene was designed according to the encoding characteristics of insect cells and inserted into pFastBac TM 1 vector with 6 × His-tag-fused N protein for expression in insect sf21 cells. Six anti–N mAbs (4G3, 5B3, 12B6, 18C7-A2, 21H10-A3, 21H10-E9) were prepared by recombinant N protein. The mAbs showed high titers, antibody affinity, and reactivity with the SARS-CoV-2 N protein. Then, fourteen overlapped peptides that covered the intact N protein were synthesized (N1-N14). Peptide N14 was identified as the main linear B-cell epitope region via peptide-ELISA and dot-blot assay, and this region was truncated gradually until mapping the peptide 401-DFSKQLQQ-408. Simultaneously, compared with the sequence of variants of concern (VOCs) and variants of interest (VOIs) strains among the several countries, epitope 401-DFSKQLQQ-408 is very conservative among them. The findings provide new guidance for the design and detection of COVID-19 targets. Key points • The N protein was optimized according to the insect cell codon preference and was highly expressed. • The monoclonal antibodies prepared in this study were shown high antibody titers and high affinity. • Monoclonal antibodies were used to map the epitope 401–408 amino acids of N protein for the first time in this study.</description><identifier>ISSN: 0175-7598</identifier><identifier>EISSN: 1432-0614</identifier><identifier>DOI: 10.1007/s00253-022-11769-6</identifier><identifier>PMID: 35037999</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Affinity ; Amino acids ; Antibodies, Monoclonal ; Antibodies, Viral ; Antigenic determinants ; Antigens ; B cells ; Biomedical and Life Sciences ; Biotechnologically Relevant Enzymes and Proteins ; Biotechnology ; Chemical properties ; Coronaviruses ; COVID-19 ; Enzyme-linked immunosorbent assay ; Epitope Mapping ; Epitopes, B-Lymphocyte ; Humans ; Identification and classification ; Immune response ; Immunomodulation ; Insect cells ; Insects ; Life Sciences ; Lymphocytes B ; Microbial Genetics and Genomics ; Microbiology ; Monoclonal antibodies ; N gene ; N protein ; Nucleocapsid Proteins - genetics ; Nucleocapsids ; Packaging ; Pathogenesis ; Peptide mapping ; Peptides ; Physiological aspects ; Proteins ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Spike Glycoprotein, Coronavirus ; Target detection ; Transcription ; Viral diseases ; Viruses</subject><ispartof>Applied microbiology and biotechnology, 2022-02, Vol.106 (3), p.1151-1164</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><rights>COPYRIGHT 2022 Springer</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-221ef80537eba2e13921460c607e3f8e627bc927e957ce90068087d1738629b43</citedby><cites>FETCH-LOGICAL-c471t-221ef80537eba2e13921460c607e3f8e627bc927e957ce90068087d1738629b43</cites><orcidid>0000-0003-1661-8174</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2625411693/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2625411693?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,11688,27924,27925,36060,36061,44363,74895</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35037999$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tian, Yuanyuan</creatorcontrib><creatorcontrib>Zhang, Gaiping</creatorcontrib><creatorcontrib>Liu, Hongliang</creatorcontrib><creatorcontrib>Ding, Peiyang</creatorcontrib><creatorcontrib>Jia, Rui</creatorcontrib><creatorcontrib>Zhou, Jingming</creatorcontrib><creatorcontrib>Chen, Yumei</creatorcontrib><creatorcontrib>Qi, Yanhua</creatorcontrib><creatorcontrib>Du, Jinran</creatorcontrib><creatorcontrib>Liang, Chao</creatorcontrib><creatorcontrib>Zhu, Xifang</creatorcontrib><creatorcontrib>Wang, Aiping</creatorcontrib><title>Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies</title><title>Applied microbiology and biotechnology</title><addtitle>Appl Microbiol Biotechnol</addtitle><addtitle>Appl Microbiol Biotechnol</addtitle><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the coronavirus disease (COVID-19). It is confirmed that nucleocapsid (N) protein is closely related to viral pathogenesis, modulation of host immune response, RNA transcription, and replication and virus packaging. Therefore, the N protein is a preponderant antigen target for virus detection. The codon-optimized N gene was designed according to the encoding characteristics of insect cells and inserted into pFastBac TM 1 vector with 6 × His-tag-fused N protein for expression in insect sf21 cells. Six anti–N mAbs (4G3, 5B3, 12B6, 18C7-A2, 21H10-A3, 21H10-E9) were prepared by recombinant N protein. The mAbs showed high titers, antibody affinity, and reactivity with the SARS-CoV-2 N protein. Then, fourteen overlapped peptides that covered the intact N protein were synthesized (N1-N14). Peptide N14 was identified as the main linear B-cell epitope region via peptide-ELISA and dot-blot assay, and this region was truncated gradually until mapping the peptide 401-DFSKQLQQ-408. Simultaneously, compared with the sequence of variants of concern (VOCs) and variants of interest (VOIs) strains among the several countries, epitope 401-DFSKQLQQ-408 is very conservative among them. The findings provide new guidance for the design and detection of COVID-19 targets. Key points • The N protein was optimized according to the insect cell codon preference and was highly expressed. • The monoclonal antibodies prepared in this study were shown high antibody titers and high affinity. • Monoclonal antibodies were used to map the epitope 401–408 amino acids of N protein for the first time in this study.</description><subject>Affinity</subject><subject>Amino acids</subject><subject>Antibodies, Monoclonal</subject><subject>Antibodies, Viral</subject><subject>Antigenic determinants</subject><subject>Antigens</subject><subject>B cells</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnologically Relevant Enzymes and Proteins</subject><subject>Biotechnology</subject><subject>Chemical properties</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Epitope Mapping</subject><subject>Epitopes, B-Lymphocyte</subject><subject>Humans</subject><subject>Identification and classification</subject><subject>Immune response</subject><subject>Immunomodulation</subject><subject>Insect cells</subject><subject>Insects</subject><subject>Life Sciences</subject><subject>Lymphocytes B</subject><subject>Microbial Genetics and Genomics</subject><subject>Microbiology</subject><subject>Monoclonal antibodies</subject><subject>N gene</subject><subject>N protein</subject><subject>Nucleocapsid Proteins - genetics</subject><subject>Nucleocapsids</subject><subject>Packaging</subject><subject>Pathogenesis</subject><subject>Peptide mapping</subject><subject>Peptides</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Spike Glycoprotein, Coronavirus</subject><subject>Target detection</subject><subject>Transcription</subject><subject>Viral diseases</subject><subject>Viruses</subject><issn>0175-7598</issn><issn>1432-0614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>M0C</sourceid><recordid>eNp9kk2LFDEQhoMo7jj6BzxIwIuXXvPRnY-LMA6uCguCo15DOl09m6UnaZNu0X-_6Z111xWRBAJVT72VKl6EnlNySgmRrzMhrOEVYayiVApdiQdoRWvOKiJo_RCtCJVNJRutTtCTnC8JoUwJ8Rid8IZwqbVeoZ87lwCCD3tsQ4d9B2HyvXd28jHg2OO32MEwYBj9FEdYItMF4DC7AaKzY_YdHlOcwAdc7m7zeVdt47eK4Tkvogt8iCG6IQY7lB6Tb2PnIT9Fj3o7ZHh2867R17N3X7YfqvNP7z9uN-eVqyWdKsYo9Io0XEJrGVCuGa0FcYJI4L0CwWTrNJOgG-lAEyIUUbKjkivBdFvzNXpz1B3n9gCdK_MlO5gx-YNNv0y03tzPBH9h9vGHUVKwuuxpjV7dCKT4fYY8mYPPy05sgDhnwwQjUirFRUFf_oVexjmVua-ppqZUaH5H7e0Axoc-lr5uETUboalWrJGqUKf_oMrp4OBdDND7Er9XwI4FLsWcE_S3M1JiFr-Yo19M8Yu59otZfvziz-3clvw2SAH4EcglFfaQ7kb6j-wVvJDJlw</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Tian, Yuanyuan</creator><creator>Zhang, Gaiping</creator><creator>Liu, Hongliang</creator><creator>Ding, Peiyang</creator><creator>Jia, Rui</creator><creator>Zhou, Jingming</creator><creator>Chen, Yumei</creator><creator>Qi, Yanhua</creator><creator>Du, Jinran</creator><creator>Liang, Chao</creator><creator>Zhu, Xifang</creator><creator>Wang, Aiping</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>LK8</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1661-8174</orcidid></search><sort><creationdate>20220201</creationdate><title>Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies</title><author>Tian, Yuanyuan ; Zhang, Gaiping ; Liu, Hongliang ; Ding, Peiyang ; Jia, Rui ; Zhou, Jingming ; Chen, Yumei ; Qi, Yanhua ; Du, Jinran ; Liang, Chao ; Zhu, Xifang ; Wang, Aiping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-221ef80537eba2e13921460c607e3f8e627bc927e957ce90068087d1738629b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Affinity</topic><topic>Amino acids</topic><topic>Antibodies, Monoclonal</topic><topic>Antibodies, Viral</topic><topic>Antigenic determinants</topic><topic>Antigens</topic><topic>B cells</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnologically Relevant Enzymes and Proteins</topic><topic>Biotechnology</topic><topic>Chemical properties</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Epitope Mapping</topic><topic>Epitopes, B-Lymphocyte</topic><topic>Humans</topic><topic>Identification and classification</topic><topic>Immune response</topic><topic>Immunomodulation</topic><topic>Insect cells</topic><topic>Insects</topic><topic>Life Sciences</topic><topic>Lymphocytes B</topic><topic>Microbial Genetics and Genomics</topic><topic>Microbiology</topic><topic>Monoclonal antibodies</topic><topic>N gene</topic><topic>N protein</topic><topic>Nucleocapsid Proteins - genetics</topic><topic>Nucleocapsids</topic><topic>Packaging</topic><topic>Pathogenesis</topic><topic>Peptide mapping</topic><topic>Peptides</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Spike Glycoprotein, Coronavirus</topic><topic>Target detection</topic><topic>Transcription</topic><topic>Viral diseases</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tian, Yuanyuan</creatorcontrib><creatorcontrib>Zhang, Gaiping</creatorcontrib><creatorcontrib>Liu, Hongliang</creatorcontrib><creatorcontrib>Ding, Peiyang</creatorcontrib><creatorcontrib>Jia, Rui</creatorcontrib><creatorcontrib>Zhou, Jingming</creatorcontrib><creatorcontrib>Chen, Yumei</creatorcontrib><creatorcontrib>Qi, Yanhua</creatorcontrib><creatorcontrib>Du, Jinran</creatorcontrib><creatorcontrib>Liang, Chao</creatorcontrib><creatorcontrib>Zhu, Xifang</creatorcontrib><creatorcontrib>Wang, Aiping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ProQuest Biological Science Collection</collection><collection>ABI/INFORM Global</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Applied microbiology and biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tian, Yuanyuan</au><au>Zhang, Gaiping</au><au>Liu, Hongliang</au><au>Ding, Peiyang</au><au>Jia, Rui</au><au>Zhou, Jingming</au><au>Chen, Yumei</au><au>Qi, Yanhua</au><au>Du, Jinran</au><au>Liang, Chao</au><au>Zhu, Xifang</au><au>Wang, Aiping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies</atitle><jtitle>Applied microbiology and biotechnology</jtitle><stitle>Appl Microbiol Biotechnol</stitle><addtitle>Appl Microbiol Biotechnol</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>106</volume><issue>3</issue><spage>1151</spage><epage>1164</epage><pages>1151-1164</pages><issn>0175-7598</issn><eissn>1432-0614</eissn><abstract>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the coronavirus disease (COVID-19). It is confirmed that nucleocapsid (N) protein is closely related to viral pathogenesis, modulation of host immune response, RNA transcription, and replication and virus packaging. Therefore, the N protein is a preponderant antigen target for virus detection. The codon-optimized N gene was designed according to the encoding characteristics of insect cells and inserted into pFastBac TM 1 vector with 6 × His-tag-fused N protein for expression in insect sf21 cells. Six anti–N mAbs (4G3, 5B3, 12B6, 18C7-A2, 21H10-A3, 21H10-E9) were prepared by recombinant N protein. The mAbs showed high titers, antibody affinity, and reactivity with the SARS-CoV-2 N protein. Then, fourteen overlapped peptides that covered the intact N protein were synthesized (N1-N14). Peptide N14 was identified as the main linear B-cell epitope region via peptide-ELISA and dot-blot assay, and this region was truncated gradually until mapping the peptide 401-DFSKQLQQ-408. Simultaneously, compared with the sequence of variants of concern (VOCs) and variants of interest (VOIs) strains among the several countries, epitope 401-DFSKQLQQ-408 is very conservative among them. The findings provide new guidance for the design and detection of COVID-19 targets. Key points • The N protein was optimized according to the insect cell codon preference and was highly expressed. • The monoclonal antibodies prepared in this study were shown high antibody titers and high affinity. • Monoclonal antibodies were used to map the epitope 401–408 amino acids of N protein for the first time in this study.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>35037999</pmid><doi>10.1007/s00253-022-11769-6</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-1661-8174</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0175-7598
ispartof Applied microbiology and biotechnology, 2022-02, Vol.106 (3), p.1151-1164
issn 0175-7598
1432-0614
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8762450
source ABI/INFORM Global; Springer Link
subjects Affinity
Amino acids
Antibodies, Monoclonal
Antibodies, Viral
Antigenic determinants
Antigens
B cells
Biomedical and Life Sciences
Biotechnologically Relevant Enzymes and Proteins
Biotechnology
Chemical properties
Coronaviruses
COVID-19
Enzyme-linked immunosorbent assay
Epitope Mapping
Epitopes, B-Lymphocyte
Humans
Identification and classification
Immune response
Immunomodulation
Insect cells
Insects
Life Sciences
Lymphocytes B
Microbial Genetics and Genomics
Microbiology
Monoclonal antibodies
N gene
N protein
Nucleocapsid Proteins - genetics
Nucleocapsids
Packaging
Pathogenesis
Peptide mapping
Peptides
Physiological aspects
Proteins
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Spike Glycoprotein, Coronavirus
Target detection
Transcription
Viral diseases
Viruses
title Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A03%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Screening%20and%20identification%20of%20B%20cell%20epitope%20of%20the%20nucleocapsid%20protein%20in%20SARS-CoV-2%20using%20the%20monoclonal%20antibodies&rft.jtitle=Applied%20microbiology%20and%20biotechnology&rft.au=Tian,%20Yuanyuan&rft.date=2022-02-01&rft.volume=106&rft.issue=3&rft.spage=1151&rft.epage=1164&rft.pages=1151-1164&rft.issn=0175-7598&rft.eissn=1432-0614&rft_id=info:doi/10.1007/s00253-022-11769-6&rft_dat=%3Cgale_pubme%3EA691982578%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c471t-221ef80537eba2e13921460c607e3f8e627bc927e957ce90068087d1738629b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2625411693&rft_id=info:pmid/35037999&rft_galeid=A691982578&rfr_iscdi=true